Pulmonary hypertension continues to be an increasing concern for researchers and health partitioners alike, given the high mortality rate and serious side effects associated with the disease. While the research end of addressing PH continues to advance promising, new therapies, leading hospitals such as Sanford Heart Hospital and Sanford Pulmonary Medicine Clinic are making their own advancements in improving pulmonary hypertension patient care, having just announced that they have launched Sanford Pulmonary Hypertension Clinic. The health system focuses on extending the length and quality of life for patients with pulmonary hypertension by combining expertise of the medical team.
The new team at the clinic consists of a pulmonologist, a cardiologist, specially trained nurses, respiratory therapists and pharmacists to deliver a multidisciplinary approach. Dr. Orvar Jonsson, a cardiologist, and the pulmonologist Dr. John Yu from Sanford Heart Hospital, are currently leading the multidisciplinary team and review each patient’s case to create a specific care plan for their PH issues.
In patients with pulmonary hypertension, the arteries leading from the heart to the lung are damaged and become narrow, blood flow decreases and the right ventricle is strained. The causes include variety of reasons such as heart, lung or liver disease, blood clots in the lungs, connective tissue disease, exposure to certain drugs or genetics. Currently there is no cure for pulmonary hypertension, however, the symptoms can be controlled and the disease progression could be slowed down.